CRISPR-Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges.

Front Neurol · 2025 · PMC12887895 · PMID 41674784

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

The integration of CRISPR-based methodologies with other treatment strategies such as RNA interference (RNAi), antisense oligonucleotides (ASOs), and small molecule pharmaceuticals is a significant trend.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.